Masitinib
-
Catalog number2007-25
-
PricePlease ask
-
Size25 mg
-
-
Alternative_nameAB-1010
-
DescriptionCell-permeable. A protein tyrosine kinase (PTK) inhibitor. targeting KIT that is active, orally bioavailable in vivo, and has low toxicity. Masitinib also potently inhibited recombinant PDGFR and the intracellular kinase Lyn, and to a lesser extent, fibroblast growth factor receptor 3. In contrast, masitinib demonstrated weak inhibition of ABL and c-Fms and was inactive against a variety of other tyrosine and serine/threonine kinases.
-
CAS Number790299-79-5
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₂₈H₃₀N₆OS
-
Molecular Weight498.64
-
Cell PermeableYes
-
Purity≥99% by HPLC
-
SolubilitiesDMSO (>100 mg/ml) or EtOH (4 mg/ml)
-
HandlingProtect from air and light
-
Tag LineA potent c-KIT, PDGF and FGFR nhibitor
-
Storage Condition-20°C
-
Shipping Conditiongel pack
-
Shelf Life24months
-
MDL NumberMFCD09954132
-
PubChem CID10074640
-
SMILESCC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC(=CS4)C5=CN=CC=C5
-
InChiInChI=1S/C28H30N6OS/c1-20-5-10-24(16-25(20)31-28-32-26(19-36-28)23-4-3- 11-29-17-23)30-27(35)22-8-6-21(7-9-22)18-34-14-12-33(2)13-15-34/h3-11, 16-17,19H,12-15,18H2,1-2H3,(H,30,35)(H,31,32)
-
InChi KeyWJEOLQLKVOPQFV-UHFFFAOYSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameMasitinib
-
Alternative nameMasitinib
-